Quipt Home Medical Corp. Files Proxy Materials

TL;DR

Quipt Home Medical Corp. filed proxy docs, shareholder meeting soon.

AI Summary

Quipt Home Medical Corp. filed a Definitive Additional Materials proxy statement on January 27, 2025. This filing relates to the company's proxy materials, indicating a shareholder meeting or vote is approaching. The company, formerly known as Protech Home Medical Corp. and Patient Home Monitoring Corp., is headquartered in Wilder, KY.

Why It Matters

This filing signals upcoming shareholder decisions or meetings, which could impact the company's governance and strategic direction.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain information about significant financial changes or risks.

Key Players & Entities

• Quipt Home Medical Corp. (company) — Registrant
• Protech Home Medical Corp. (company) — Former company name
• Patient Home Monitoring Corp. (company) — Former company name

FAQ

Filing Documents

• qipt-20250127xdefa14a.htm (DEFA14A) — 12KB
• qipt-20250127xdefa14a_bg001.jpg (GRAPHIC) — 152KB
• qipt-20250127xdefa14a_bg002.jpg (GRAPHIC) — 84KB
• 0001558370-25-000419.txt ( ) — 333KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Quipt Home Medical Corp. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 Your Vote Counts! QUIPT HOME MEDICAL CORP. 2025 Annual Meeting Vote by March 12, 2025 11 :59 PM ET You invested in QUIPT HOME MEDICAL CORP. and it's time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on March 17, 2025. Get informed before you vote View the Notice and Management Information and Proxy Circular, Annual Report on Form 10-K, Financial Statement Request Form online OR you can receive a free paper or email copy of the material(s) by requesting prior to March 03, 2025. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800- 579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Smartphone users Point your camera here and � vote without entering a I number Vote in Person at the Meeting* March 17, 2025 10:00 AM EDT Hampton Inn & Suites 975 University Parkway Sarasota, Florida *If you choose to vote these shares in person at the meeting, you must request a "legal proxy." To do so, please follow the instructions at www.ProxyVote.com or request a paper copy of the materials, which will contain the appropriate instructions. Please check the meeting materials for any special requirements for meeting attendance. Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. Voting Items 1. Election of Directors Nominees: 1 A Gregory Crawford 1 B Mark Greenberg 1 C Kevin Carter 1 D Brian Wessel QUIPT HOME MEDICAL CORP. 2025 Annual Meeting Vote by March 12, 2025 11:59PMET 2 Re-appointment of BOO USA, P.C. as auditors of the Corporation to hold office until the next annual meeting of shareholders and the authorization of the directors of the Corporation to fix their remuneration. NOTE: Such other business as may properly come before the meeting or any adjournment thereof. Board Recommends 0For 0For 0For 0For 0For

View Full Filing

View this DEFA14A filing on SEC EDGAR